What is rheumatoid arthritis?
Rheumatoid arthritis is a chronic autoimmune disease. That means your immune system, which is supposed to protect you from infections, mistakenly attacks your own body. In RA, the main target is the lining of your joints, called the synovium. When the synovium becomes inflamed, it thickens, produces excess fluid, and over time can erode cartilage and bone.[2]
RA is not the same as osteoarthritis, which is the wear-and-tear joint disease most people are familiar with. RA is driven by inflammation, not age-related degeneration. It can affect people in their 30s, 40s, and 50s, sometimes even younger. And unlike osteoarthritis, which mainly causes local joint damage, RA is a systemic disease, meaning it can affect your whole body, including your heart, lungs, eyes, and blood.[3]
The most important thing to understand about RA is that early treatment significantly changes the course of the disease. Irreversible joint damage can begin within the first two years, sometimes within months.[1] Getting diagnosed and starting treatment quickly is the single most effective thing that can happen for your long-term joint health and quality of life.
Symptoms of rheumatoid arthritis
RA most typically starts gradually. Many people describe weeks or even months of vague fatigue, aching, and stiffness before they notice obvious joint swelling. For others, symptoms come on more suddenly. No two people experience RA exactly the same way.[4]
The joints most commonly affected first are the small joints of the hands, wrists, and feet, particularly the knuckles (metacarpophalangeal joints), the middle joints of the fingers (proximal interphalangeal joints), and the joints at the base of the toes.[2] One of the hallmarks of RA is that joint involvement often becomes symmetric, meaning both hands or both feet are affected. That said, very early RA does not always start that way. Some people notice only one wrist or a few joints at first before the pattern becomes clearer over weeks or months.[4]
How doctors diagnose rheumatoid arthritis
There is no single test that confirms RA. Diagnosis is a clinical process, meaning your doctor puts together the full picture: your symptoms, their duration, the pattern of your joint involvement, your physical exam findings, your blood tests, and sometimes imaging.[2]
A key point that surprises many patients: you can have RA even if your blood tests come back negative. About 20 to 30 percent of people with RA are seronegative, meaning RF and anti-CCP antibodies are not detectable in their blood. This is called seronegative RA, and it is a real diagnosis made based on clinical features.[2]
Common labs and tests in RA
If you have received a blood test result and are trying to understand what it means, the guides below cover each test in detail. Here is a brief overview of what gets ordered and why.
| Test | What it measures | What to know |
|---|---|---|
| RF (Rheumatoid Factor) | An antibody associated with RA. Positive in about 60-70% of RA patients.[2] | Not specific to RA. Can be positive in many other conditions and in healthy older adults. A negative RF does not rule out RA. |
| Anti-CCP | A more specific antibody for RA. Specificity of approximately 95%.[2] | A positive anti-CCP in someone with joint swelling is a strong signal. Can appear years before symptoms develop. Does not diagnose RA alone. |
| CRP | A direct marker of active inflammation produced by the liver.[6] | Rises and falls quickly with disease activity. Useful for tracking whether treatment is working. Can be normal in mild or well-controlled RA. |
| ESR (Sed Rate) | An indirect measure of inflammation based on how fast red cells settle in a tube.[6] | Slower to change than CRP. Affected by age, sex, anemia, and other factors. Often elevated in active RA but can be normal. |
| CBC | Complete blood count — checks red cells, white cells, and platelets. | Anemia is common in active RA. Mildly elevated platelet count can also indicate active inflammation. Some medications require regular CBC monitoring. |
| Liver and kidney function | Checks how well the liver and kidneys are working. | Required before starting DMARDs and during ongoing treatment, as some medications can affect these organs.[1] |
Treatment overview
The treatment of RA has been transformed over the past two to three decades. Most people diagnosed today, especially when caught early, can achieve remission or low disease activity and live full, active lives. The goal of treatment is not just symptom relief. It is to stop inflammation, protect your joints from damage, and preserve your ability to function.[1]
Treatment is built around a class of medications called DMARDs, which stands for disease-modifying antirheumatic drugs. Unlike pain relievers or anti-inflammatories, DMARDs address the underlying immune process driving the disease. They are not a cure, but they change the course of RA in a way that symptomatic medications alone cannot.[1]
The approach is called treat to target: your doctor will measure disease activity regularly and adjust your medications until you reach a defined target, usually remission or low disease activity. This strategy of frequent reassessment and adjustment has been shown to produce significantly better joint and functional outcomes compared with less structured approaches.[1]
IL-6 inhibitors: Tocilizumab (Actemra), sarilumab (Kevzara)
Other: Abatacept (Orencia), rituximab (Rituxan)
What monitoring means in RA
RA is a lifelong condition. Even when your disease is well controlled, regular monitoring is an essential part of your care. Monitoring serves two purposes: tracking your disease activity so your treatment can be adjusted, and watching for side effects from your medications.[1]
Your rheumatologist will use formal disease activity scores at most visits, not just ask how you are feeling. These scoring tools combine your joint count, inflammation markers, and how you rate your own health. Examples include the DAS28, CDAI, and SDAI. These scores give a quantitative measure of how active your RA is and help guide treatment decisions.[1]
| When | What your doctor is checking |
|---|---|
| Every 3 months until stable | Joint counts, disease activity score, CRP and ESR, medication safety labs (CBC, liver, kidney). Treatment is adjusted if the target has not been reached.[1] |
| Every 3-6 months when in remission | Continued monitoring of disease activity and medication safety. If you remain stable, visits may be spaced further apart.[1] |
| Baseline before starting or changing DMARDs | Hepatitis B and C screening, tuberculosis screening before biologics or JAK inhibitors, baseline blood work before methotrexate (and sometimes a chest X-ray depending on your history and risk factors), eye exam before hydroxychloroquine, lipid panel before IL-6 or JAK inhibitors.[1] |
| When things change | If your joints flare, you develop new symptoms, start an infection, or are considering pregnancy, contact your rheumatologist. Do not wait for your next scheduled visit.[1] |
RA beyond the joints
RA is a systemic disease, meaning it can affect more than just your joints. Severe extraarticular disease is much less common than joint symptoms, especially when RA is recognized and treated early. But it is worth knowing that RA can affect other systems, and some of these complications are manageable if caught early.[3]
Cardiovascular risk is elevated in RA. People with RA have a higher risk of heart disease, heart failure, and stroke, partly from the inflammation itself and partly from some medications.[3] Because of this, routine preventive care becomes especially important: managing blood pressure and cholesterol, not smoking, staying active, and keeping inflammation controlled all help reduce cardiovascular risk.
Smoking is one of the most important modifiable risk factors in RA. Smoking is associated with a higher risk of developing RA, worse disease activity, poorer treatment response, and more extraarticular complications.[3] Quitting smoking is one of the most meaningful steps a person with RA can take beyond their medications. If you smoke, ask your doctor about resources to help you stop.
Bone density decreases. RA causes bone loss both from the inflammatory process itself and from glucocorticoid treatment. People with RA have a meaningfully higher risk of osteoporotic fractures compared with people without RA.[3] Bone density assessment, calcium and vitamin D supplementation, and sometimes medication are part of comprehensive RA care.
Fatigue is real and common. Fatigue in RA is multifactorial, driven by pain, poor sleep, inflammation, and sometimes depression. It is not simply tiredness, and it is not something you should dismiss or push through without addressing. About one in five people with RA also has co-existing fibromyalgia, which can amplify pain and fatigue independently of joint inflammation.[3]
Lung and eye involvement can occur. Lung disease, including interstitial lung disease and pleuritis, occurs in a subset of patients, particularly those with high RF levels or longstanding disease. Eye involvement, including dry eyes, scleritis, and episcleritis, can also occur. New respiratory symptoms or significant eye pain or vision changes in someone with RA should be evaluated promptly.[3]
Depression is more common in RA. Affective disorders, particularly depression, are significantly more prevalent in people with RA. Depression in RA is associated with increased pain, fatigue, and disability. It is not a weakness, and it is worth discussing with your doctor.[3]
Pregnancy planning requires advance coordination. Some RA medications, including methotrexate and leflunomide, are not safe during pregnancy and may need to be stopped well before conception. Other medications are considered compatible with pregnancy. Tell your rheumatologist early if you are pregnant, trying to conceive, or breastfeeding so your treatment can be planned accordingly.[1]
Questions to ask your doctor
Rheumatology appointments can feel overwhelming, especially early in the diagnostic process. Having questions prepared helps you leave with clarity. Here are questions worth asking at your first few visits:
Things people often ask
I was told my blood tests are negative. Can I still have RA? ▼
Yes. About 20 to 30 percent of people with RA test negative for both RF and anti-CCP antibodies, a pattern called seronegative RA.[2] The diagnosis in this case is made on clinical grounds: the pattern of joint involvement, exam findings, imaging, and response to treatment over time.
When both antibodies are negative, your doctor will also think carefully about conditions that can look similar to RA, including psoriatic arthritis, viral arthritis, crystal disease like gout, and spondyloarthritis. Negative labs mean the diagnosis may take longer to establish, not that your symptoms are not real. If you have persistent joint swelling that your doctor cannot explain, pursue evaluation regardless of your antibody results.
Will I need to be on medication forever? ▼
Most people need some form of long-term treatment to keep RA controlled. Stopping all medication is associated with a high risk of disease flare, even in people who have been in remission for years.[1]
That said, if you achieve sustained remission for more than a year, your rheumatologist may cautiously reduce your dose. The goal in this case is the lowest effective dose, not necessarily stopping entirely. Drug-free remission, while it occasionally happens, is rare and cannot be reliably predicted in advance.
Is RA hereditary? Will my children develop it? ▼
Genetics plays a role in RA, but having RA does not mean your children will develop it. Having a parent with RA increases their risk somewhat, but most children of people with RA will never develop it. RA is not caused by a single gene. It involves a combination of genetic predisposition and environmental factors, with smoking being one of the strongest known modifiable risk factors.[2]
First-degree relatives of people with RA do have a modestly higher risk than the general population, but the absolute risk remains low for any individual family member.
Can I exercise with RA? ▼
Yes. Regular exercise is usually encouraged in RA and is an important part of maintaining strength, joint function, cardiovascular health, and mood. Both aerobic exercise and strength training can be beneficial when adjusted to your symptoms and current fitness level.[3]
During a flare, you may need to temporarily reduce or modify activities that put heavy stress on actively inflamed joints. Your rheumatologist or a physical therapist can help you find the safest and most effective approach for your situation.
Can I get pregnant if I have RA? ▼
Yes, many people with RA have successful pregnancies. However, planning ahead with your rheumatologist is essential. Some medications, especially methotrexate and leflunomide, are not safe during pregnancy and may need to be stopped well before conception. Other RA medications are considered compatible with pregnancy and can often be continued.[1]
RA itself often improves during pregnancy for many people, though flares are common in the months after delivery. Tell your rheumatologist early if you are pregnant, trying to conceive, or breastfeeding so your treatment can be adjusted accordingly and your pregnancy can be monitored appropriately.
My joints hurt but my X-ray looks normal. Does that mean nothing is wrong? ▼
No. Plain X-rays are often normal in early RA. Bone erosions usually develop later in the disease, so a normal X-ray does not rule out inflammatory arthritis.[2]
If your symptoms, physical exam, or lab results suggest RA, your doctor will rely on the overall clinical picture rather than the X-ray alone. Ultrasound or MRI may be ordered to look for early inflammation or joint changes that plain films cannot show.
What is the difference between RA and osteoarthritis? ▼
They are very different conditions that can both cause joint pain, but the underlying cause and the treatment approach are completely different. Osteoarthritis is a wear-and-tear condition caused by the gradual breakdown of cartilage, typically in older adults. It tends to affect weight-bearing joints like hips and knees, and the outermost knuckles (DIP joints) in the hands. The joint swelling in osteoarthritis feels hard and bony, and stiffness usually eases within a few minutes of moving around.[2]
RA is an autoimmune disease where the immune system attacks the joint lining. It tends to affect the large knuckles (MCP joints), the middle knuckles (PIP joints), and the wrists. The swelling feels soft and boggy rather than hard. Morning stiffness lasting more than an hour is characteristic of RA, while osteoarthritis stiffness is typically brief. RA can also affect younger people and comes with systemic symptoms like fatigue that osteoarthritis does not cause. Blood tests, physical exam findings, and imaging help distinguish between them.[2]
RA calculators for clinicians
AutoimmuneCalc maintains a full suite of validated rheumatoid arthritis disease activity calculators for clinicians, including DAS28-CRP, DAS28-ESR, CDAI, SDAI, RAPID3, and HAQ.
- Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3-18. Also: Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924-939.
- Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-2581.
- Turesson C, O'Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722-727.
- Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(9285):903-911.
- Wakefield RJ, Gibbon WW, Conaghan PG, et al. The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis. Arthritis Rheum. 2000;43(12):2762-2770. Also: McQueen FM. The use of MRI in early RA. Rheumatology (Oxford). 2008;47(1):1597.
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-454.
- Studenic P, Aletaha D, de Wit M, et al. American College of Rheumatology/EULAR Remission Criteria for Rheumatoid Arthritis: 2022 Revision. Arthritis Rheumatol. 2023;75(1):15-22.